Australia Neurothrombectomy Devices Market Size & Outlook
Australia neurothrombectomy devices market, 2018-2030 (US$M)
Related Markets
Australia neurothrombectomy devices market highlights
- The Australia neurothrombectomy devices market generated a revenue of USD 17.6 million in 2023 and is expected to reach USD 27.3 million by 2030.
- The Australia market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, clot retrievers was the largest revenue generating product in 2023.
- Aspiration/Suction Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Neurothrombectomy devices market data book summary
| Market revenue in 2023 | USD 17.6 million |
| Market revenue in 2030 | USD 27.3 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Clot retrievers |
| Fastest growing segment | Aspiration/Suction Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clot Retrievers, Aspiration/Suction Devices, Vascular Snares |
| Key market players worldwide | Medtronic PLC, Acandis GmbH, Stryker Corp, Penumbra Inc, Phenox, Vesalio |
Other key industry trends
- In terms of revenue, Australia accounted for 2.5% of the global neurothrombectomy devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China neurothrombectomy devices market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 46.5 million by 2030.
Clot retrievers was the largest segment with a revenue share of 58.52% in 2023. Horizon Databook has segmented the Australia neurothrombectomy devices market based on clot retrievers, aspiration/suction devices, vascular snares covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing incidence of stroke and rising healthcare expenditure in Australia are major factors promoting market growth over the forecast period. For instance, as per study published by the Stroke Foundation in 2018, stroke is one of the leading causes of deaths in Australia and in 2017 there were more than 56,000 recurrent and new stroke cases reported in Australia.
Similarly, as per the report published by Australian Institute of Health and Welfare in 2018, around 8,200 deaths were recorded due to stroke, which almost accounted for 5.20% of all deaths in Australia in 2016.
Such instances are anticipated to positively impact the market. In addition, as per the report published by the Australian Institute of Health and Welfare in 2018, government funding is around two-thirds of all healthcare spending and nongovernment funding is around 33.00%. Therefore, such instances may encourage many new and key players to enter the market, thereby propelling the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurothrombectomy Devices Market Scope
Neurothrombectomy Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia neurothrombectomy devices market size, by product, 2018-2030 (US$M)
Australia Neurothrombectomy Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
